Safety and Feasibility of Chimeric Antigen Receptor T Cell Therapy after Allogeneic Stem Cell Therapy in Relapsed/ Refractory B Cell Lymphomas

Autor: Jain, Tania, Sauter, Craig S., Shah, Gunjan L., Maloy, Molly A., Chan, Jason, Scordo, Michael, Avecilla, Scott T., Batlevi, Yakup, Dahi, Parastoo B, Batlevi, Connie W, Palomba, M. Lia, Giralt, Sergio A., Perales, Miguel-Angel
Zdroj: In Biology of Blood and Marrow Transplantation March 2019 25(3) Supplement:S183-S184
Databáze: ScienceDirect